Editor's choice:Comparison between five N-acetylgalactosamine-conjugated siRNAs in several mouse models of liver cancer found ANLN to be a promising target for hepatocellular carcinoma chemoprevention. The gene discussed is ANLN; the disease is hepatocellular carcinoma.